Prof Debu Tripathy speaks to ecancer at BGICC 2019 in Cairo about the development of treatments for premenopausal patients with breast cancer.

He explains that most of the investigation into endocrine treatments have been in regards to the postmenopausal years.

This is due to the majority of patients presenting in the postmenopausal years but also due to successful endocrine treatments being developed that were not applicable in premenopausal breast cancer.

Prof Tripathy discusses the MONALEESA-7 trial dedicated to premenopausal patients which looked at the use of ribociclib plus endocrine therapy and produced similar results to these patients compared to postmenopausal patients.